A foundation of success
A Celebration of IMSE’s Achievements
As IMSE closes its doors, we want to thank all our Affiliates and Partners for their contributions over the years
A Celebration of IMSE’s Achievements
As IMSE closes its doors, we want to thank all our Affiliates and Partners for their contributions over the years
DNA’s hidden shape reveals target to reverse ovarian cancer chemoresistance
An unusual DNA structure may hold the key to treating one of the deadliest cancers affecting women, which claims over 200,000 lives globally each year
Genetic clues explain why children develop rare post-COVID condition
An Imperial-led study has highlighted how rare variants of a gene regulating the gut lining may increase the risk of MIS-C by up to four times.
IMSE Masters Scholarship Interview with Yea Eun Moon
Yea Eun Moon, the Dr Theo George Wilson scholarship recipient shares her thoughts on her journey so far on the MRes in Molecular Engineering course.
Get to know the 2024-2025 Molecular Engineering Masters student!
We asked our current MRes cohort to introduce themselves in just a couple of sentences following a science communication lecture.
Visualizing molecular engineering
Imperial researchers share their best images featuring the field of molecular science and engineering for IMSE's image competition
Puraffinity raises £17m and prepares to scale up water treatment technology
With new investment and a new chief executive, Imperial startup Puraffinity is ready to take its PFAS removal system to the market.
Institute for Molecular Science and Engineering (IMSE) Research Showcase 2024
IMSE showcased how integrating expertise across diverse academic disciplines and with external stakeholders helps solve grand challenges.
Business invited to make the most of Imperial’s research facilities
When not being used for academic research or teaching Imperial’s science and engineering facilities are available to outside users.
Developing a new test to improve sepsis outcomes
In advance of World Sepsis Day, Imperial and MicrosensDx announce a collaboration to develop a more effective test for the devastating disease.